For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

PHILADELPHIA, Sept. 5, 2017 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug ...

According to the results of a phase III trial presented at the 2018 ASCO Annual Meeting, two simple over-the-counter medicines – high dose esomeprazole and low dose aspirin when taken regularly can ...

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Esomeprazole Magnesium ...

Dec. 17, 2003 — Esomeprazole is the most effective proton pump inhibitor (PPI) for gastric acid control, according to the results of a five-way crossover study published in the December issue of the ...

Nottingham, UK - Two AstraZeneca-funded studies have found that esomeprazole magnesium (Nexium) cuts gastrointestinal (GI) symptoms in patients on chronic NSAID therapy, including coxibs [ 1]. "People ...

Proton-pump inhibitors (PPIs) are an effective treatment for acid-related conditions, but their efficacy for the treatment of patients with upper gastrointestinal symptoms resulting from nonsteroidal ...

Zim Laboratories announced that it has received approval from the Central Drugs Standard Control Organization (CDSCO) for its novel fixed-dose combination (FDC) of Naproxen Delayed Release and ...

Low-dose aspirin (75–325 mg once daily), used to prevent cardiovascular events in high-risk patients, is associated with an increased risk of gastroduodenal ulceration. Esomeprazole, a proton-pump ...

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced Thursday the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. market. The tablets are a ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals LLC today announced the launch of its branded Esomeprazole Strontium 49.3 mg delayed-release capsules. Esomeprazole Strontium contains the ...

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES USP, 20 mg and 40 mg, a therapeutic equivalent generic version of NEXIUM® ...